Andrew Dunlop

Andrew Dunlop

Director/Board Member at APELLIS PHARMACEUTICALS, INC.

Net worth: 20 M $ as of 2024-03-30

52 year
Health Technology
Finance
Consumer Services

Profile

Andrew Sinclair Dunlop is the founder of Epidarex Capital Partners LLC, which was founded in 2010.
He is currently the Chairman of Inspiring Scotland, a Director at Potentia Pharmaceuticals, Inc., an Independent Director at Apellis Pharmaceuticals, Inc., and a Director at SIRAKOSS Ltd., Mironid Ltd., Edinburgh Molecular Imaging Ltd., and Reform Scotland Ltd.
He previously held positions as a Director at MaxCyte, Inc. and MediQuest Therapeutics, Inc., a Non-Executive Director at enGene, Inc., an Associate at New Vantage Group LLC, and a Managing Partner at MASA Life Science Ventures.
He also worked as a Business & Economics Analyst at the Center for Strategic & International Studies, Inc. Mr. Dunlop graduated from the University of Glasgow in 1994, the Maxwell School of Syracuse University in 1995, and received an MBA from Columbia Business School in 2000.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-11 339,371 ( 0.28% ) 20 M $ 2024-03-30

Andrew Dunlop active positions

CompaniesPositionStart
APELLIS PHARMACEUTICALS, INC. Director/Board Member 2010-02-28
Founder 2009-12-31
Director/Board Member -
Chairman 2017-12-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Andrew Dunlop

Former positions of Andrew Dunlop

CompaniesPositionEnd
MAXCYTE, INC. Director/Board Member 2016-03-14
░░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Andrew Dunlop's experience

Training of Andrew Dunlop

University of Glasgow Graduate Degree
Maxwell School of Syracuse University Graduate Degree
Columbia Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Dunlop's experience

Connections

99

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MAXCYTE, INC.

Health Technology

APELLIS PHARMACEUTICALS, INC.

Health Technology

Private companies13

Health Technology

Health Technology

Health Technology

Finance

Finance

Finance

Commercial Services

Commercial Services

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

See company connections